ENGN
Price:
$8.22
Market Cap:
$420.82M
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.
Industry
Biotechnology
IPO Date
2022-02-01
Stock Exchange
NASDAQ
Ticker
ENGN
According to enGene Holdings Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.33. This represents a change of 80.11% compared to the average of -2.40 of the last 4 quarters.
The mean historical PE Ratio of enGene Holdings Inc. over the last ten years is 2.05K. The current -4.33 PE Ratio has changed -121.13% with respect to the historical average. Over the past ten years (40 quarters), ENGN's PE Ratio was at its highest in in the April 2025 quarter at 2.05. The PE Ratio was at its lowest in in the December 2021 quarter at -367.74.
Average
2.05K
Median
-7.16
Minimum
-20.99
Maximum
10.29K
Discovering the peaks and valleys of enGene Holdings Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 51.93%
Maximum Annual PE Ratio = 10.29K
Minimum Annual Increase = -76390.44%
Minimum Annual PE Ratio = -20.99
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -7.16 | 51.93% |
| 2023 | -4.72 | -100.05% |
| 2022 | 10.29K | -76390.44% |
| 2021 | -13.49 | -35.72% |
The current PE Ratio of enGene Holdings Inc. (ENGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.43K
5-year avg
2.05K
10-year avg
2.05K
enGene Holdings Inc.’s PE Ratio is greater than Amarin Corporation plc (-79.20), greater than Altimmune, Inc. (-5.66), less than Korro Bio, Inc. (-0.70), less than DBV Technologies S.A. (-2.92), less than Larimar Therapeutics, Inc. (-2.36), greater than Cellectis S.A. (-8.40), less than Annexon, Inc. (-3.56), greater than Alto Neuroscience, Inc. (-5.58), greater than AC Immune S.A. (-4.60), less than Silence Therapeutics plc (-1.93),
| Company | PE Ratio | Market cap |
|---|---|---|
| -79.20 | $340.44M | |
| -5.66 | $468.65M | |
| -0.70 | $63.86M | |
| -2.92 | $312.18M | |
| -2.36 | $314.97M | |
| -8.40 | $484.47M | |
| -3.56 | $536.98M | |
| -5.58 | $415.67M | |
| -4.60 | $289.73M | |
| -1.93 | $336.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like enGene Holdings Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like enGene Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is enGene Holdings Inc.'s PE Ratio?
How is the PE Ratio calculated for enGene Holdings Inc. (ENGN)?
What is the highest PE Ratio for enGene Holdings Inc. (ENGN)?
What is the 3-year average PE Ratio for enGene Holdings Inc. (ENGN)?
What is the 5-year average PE Ratio for enGene Holdings Inc. (ENGN)?
How does the current PE Ratio for enGene Holdings Inc. (ENGN) compare to its historical average?